LIONHEART VENTURES — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Piramidal bridges in-vivo and in-silico intelligence for neuroscience research and clinical applications.
AI & Machine LearningBiotechHealthtechMedical DevicesNew York City, US
Dimitris Fotis Sakellariou(CEO)inKris Pahuja(CPO)inSahil Zubair(Founding Eng)Kyriacos Xanthos(Founding Eng)Yaqub Alwan(Founding Eng)
Co-investorsY CombinatorAdverb Venturesfutureland venturesGaingelsGeek VenturesRitual Capital+11 more
Mindstate Design Labs is a clinical-stage drug development company that uses AI to map the biological basis of emotion and cognition, synthesizing psychedelic phenomenology and biochemical data to design pharmaceutical compounds that induce specific therapeutic emotional and cognitive states for mental health treatment.
AI & Machine LearningBiotechHealthtechMental HealthSan Francisco, US
Dillan DiNardo(CEO)inTom Ray(Founder)inTegan Johnson(Director of Operations)
BoardRand Hindi(Director)in
Co-investorsARA NEA Ventures (Brand: Dmz.Xyz)Blast.ClubEmpath VenturesGaingelsImmeasurableInitialized Capital+14 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.






__Twitter.png)



